Medtronic executive Scott Cundy joins MiniMed (MMED) Board as Brett Wall exits
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
MiniMed Group, Inc. reported that director Brett Wall, a class II member of the Board and of the Nominating and Corporate Governance Committee, has notified the company he will resign from the Board effective July 3, 2026. The company states his decision is not due to any disagreement with management or the Board, but follows his departure from a senior leadership role at Medtronic plc, MiniMed’s parent, which originally nominated him.
To fill the vacancy, Scott Cundy was appointed as a director effective July 3, 2026. He will serve as a class II director with a term expiring at the 2027 annual meeting of stockholders and will join the Nominating and Corporate Governance Committee. Cundy is a senior Medtronic executive overseeing global quality, product development, and innovation. While Medtronic remains an affiliate of MiniMed, he will receive no compensation for Board service; if that changes, his pay will align with MiniMed’s non‑employee director program.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Wall resignation effective date: July 3, 2026
Cundy appointment date: July 3, 2026
Cundy Board term end: 2027 annual meeting
+1 more
4 metrics
Wall resignation effective date
July 3, 2026
Effective date of Brett Wall’s Board resignation
Cundy appointment date
July 3, 2026
Effective date of Scott Cundy’s Board appointment
Cundy Board term end
2027 annual meeting
End of Scott Cundy’s initial term as class II director
Exhibit 104
Cover Page Interactive Data File
Inline XBRL cover page data file listed in exhibit index
Key Terms
class II director, Nominating and Corporate Governance Committee, emerging growth company, Regulation S-K, +1 more
5 terms
class II director regulatory
"Brett Wall, a class II director of the Board of Directors"
A class II director is a member of a company’s board who belongs to one of several staggered groups of directors, each group standing for election in different years. For investors, this matters because staggered terms slow wholesale board turnover—like rotating members of a neighborhood committee—making sudden changes in control or strategy harder and affecting how quickly shareholders can influence corporate direction.
Nominating and Corporate Governance Committee regulatory
"and member of the Board’s Nominating and Corporate Governance Committee"
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Regulation S-K regulatory
"material interest in any transaction that is required to be disclosed under Item 404(a) of Regulation S-K"
A set of U.S. Securities and Exchange Commission rules that tell public companies which narrative and qualitative details must be disclosed in filings, such as risk factors, management discussion, executive pay, legal proceedings and business description. Think of it as a standardized checklist or blueprint that ensures investors get the same types of background information from every company so they can compare risks, management quality and strategy before making investment decisions.
affiliate financial
"For so long as Medtronic is an affiliate of MiniMed, Mr. Cundy, as an employee of Medtronic, will receive no compensation"
FAQ
Why is MiniMed (MMED) director Brett Wall resigning from the Board?
Brett Wall is resigning effective July 3, 2026 because he is leaving his role at Medtronic plc, MiniMed’s parent, which originally nominated him. The company states his decision is not due to any disagreement with management or the Board.
Who is replacing Brett Wall on MiniMed (MMED)’s Board of Directors?
MiniMed has appointed Scott Cundy to its Board effective July 3, 2026. He will serve as a class II director and join the Nominating and Corporate Governance Committee, filling the vacancy created by Brett Wall’s resignation from the Board.
What is Scott Cundy’s term as a MiniMed (MMED) director?
Scott Cundy will serve as a class II director with a term expiring at MiniMed’s 2027 annual meeting of stockholders. His appointment is effective July 3, 2026, when he fills the Board seat vacated by director Brett Wall.
Will MiniMed (MMED) pay Board fees to Scott Cundy immediately?
For as long as Medtronic remains an affiliate of MiniMed, Scott Cundy will receive no compensation for his Board service because he is a Medtronic employee. If that relationship changes, his director compensation will match that of other non‑employee MiniMed directors.